berberine has been researched along with bortezomib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bisen, PS; Bundela, S; Sharma, A | 1 |
| Celik, H; Comakli, S; Gur, C; Kandemir, FM; Kucukler, S; Ozdemir, S; Yardim, A | 1 |
| Fei, J; Gu, C; Huang, G; Li, C; Liu, Y; Su, R; Wang, X; Yang, J; Yin, Z | 1 |
3 other study(ies) available for berberine and bortezomib
| Article | Year |
|---|---|
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat | 2015 |
Investigation of the effects of berberine on bortezomib-induced sciatic nerve and spinal cord damage in rats through pathways involved in oxidative stress and neuro-inflammation.
Topics: Animals; Berberine; Bortezomib; Inflammation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord | 2022 |
Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma.
Topics: Animals; Apoptosis; Berberine; Bortezomib; Carcinogenesis; Cell Line, Tumor; Humans; Mice; Molecular Docking Simulation; Multiple Myeloma; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Tumor Suppressor Protein p53; Ubiquitin | 2022 |